Aspiriant LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 20.3% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 3,361 shares of the healthcare conglomerate's stock after selling 856 shares during the quarter. Aspiriant LLC's holdings in UnitedHealth Group were worth $1,049,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Nabity Jensen Investment Management Inc increased its position in UnitedHealth Group by 0.9% in the 1st quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate's stock valued at $1,446,000 after acquiring an additional 24 shares during the period. Atlantic Edge Private Wealth Management LLC increased its position in UnitedHealth Group by 8.9% in the 1st quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate's stock valued at $160,000 after acquiring an additional 25 shares during the period. Osborne Partners Capital Management LLC boosted its stake in shares of UnitedHealth Group by 2.5% in the 1st quarter. Osborne Partners Capital Management LLC now owns 1,066 shares of the healthcare conglomerate's stock valued at $558,000 after purchasing an additional 26 shares during the last quarter. HHM Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group by 0.9% in the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate's stock valued at $1,544,000 after purchasing an additional 26 shares during the last quarter. Finally, MPS Loria Financial Planners LLC boosted its stake in shares of UnitedHealth Group by 0.4% in the 1st quarter. MPS Loria Financial Planners LLC now owns 7,256 shares of the healthcare conglomerate's stock valued at $3,800,000 after purchasing an additional 27 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts have recently commented on UNH shares. Mizuho upped their price objective on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an "outperform" rating in a research note on Thursday, October 9th. The Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research note on Tuesday. They issued a "buy" rating and a $406.00 price objective on the stock. Wells Fargo & Company increased their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 7th. KeyCorp increased their target price on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 8th. Finally, Zacks Research raised shares of UnitedHealth Group from a "strong sell" rating to a "hold" rating in a research note on Monday, October 6th. Eighteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat, UnitedHealth Group presently has an average rating of "Hold" and a consensus target price of $385.13.
Get Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Stock Performance
UNH opened at $356.53 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company's fifty day moving average price is $329.38 and its two-hundred day moving average price is $344.86. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a market cap of $322.90 billion, a price-to-earnings ratio of 15.45, a PEG ratio of 2.31 and a beta of 0.47.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the company posted $6.80 EPS. The business's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio is currently 38.30%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.